Navigation Links
Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
Date:9/7/2011

Glycemic Control Independently of Diabetes Duration and Insulin Resistance in Patients with Type 2 Diabetes

Poster

832-P

S Patel, S-A Weber, A Emser,
M von Eynatten, H-J Woerle

Date: Tues, Sept. 13

Time: 1:30−2:30 p.m.Phase II (12-week)Efficacy and Safety of 5 mg Daily Dosing Regimens with Linagliptin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin

Poster

831-P

E Rafeiro, S Ross, T Meinicke, R Toorawa, H-J Woerle

Date: Tues, Sept. 13

Time: 1:30−2:30 p.m.PreclinicalEffect of Linagliptin on Infarction Size and Cardiac Function in Rats After Myocardial Ischaemia Reperfusion

Poster

811-P

T Pfab, Y Sharkovska, M Alter, K von Websky, M Mark, T Klein, B Hocher

Date: Thurs, Sept. 15

Time: 1:30−2:30 p.m.Phase III (104 week)Long-term Efficacy and Safety of the DPP-4 Inhibitor Linagliptin: Data from a Large Two-year Study in Patients with Type 2 Diabetes Mellitus

Oral Presentation

242-OP

A Schlosser, D Owens, M-R Taskinen, S Del Prato, R Gomis, S Patel, A Pivovarova, H-J Woerle

Date: Fri, Sept. 16

Time: 11:45 a.m.−12:00 p.m.Empagliflozin DataTitleFormat Authors Date/Time Phase II (12 week) ENCORE: Efficacy and Safety of BI-10773, a new Sodium Glucose Co-transporter-2 (SGLT-2) Inhibitor, in Type 2 Diabetes Patients Inadequately Controlled on Metformin

Oral Presentation

147-OP

L Seman, J Rosenstock, A Jelaska, S Pinnetti, S Hantel, H-J Woerle

Date: Thurs, Sept. 15

Time: 11:15−11:30 a.m.*All times in Western European Summer Time (WEST)Indication and Important Limitations of UseTRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

TRADJENTA should not be used in patients with type 1 diabetes or for the treatment of diabetic ke
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015  Kastle Therapeutics (Kastle), a ... pharmaceuticals for diseases with high unmet medical needs, ... to key commercial operating positions. ... Commercial; Sean was previously Global Marketing Director for ... as Director, Commercial Strategy and Analytics; Nick was ...
(Date:9/2/2015)... , Sept. 2, 2015 ... a broad spectrum of physicians who prescribe ... Association of Clinical Endocrinologists, American College of ... Rheumatology Organizations, and North American Society for ... a letter to Centers for Medicare and ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of the ... (Dubai, UAE - October 18-19, 2015)" conference ... for Ensuring Compliance with Regulatory Requirements ... GMP, QA and Document Management Functions & Regulatory ...
Breaking Medicine Technology:Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 2Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 3Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 5Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 6Pharmaceutical Regulatory Affairs Course in the Middle East, Dubai (Dubai, UAE - October 18-19, 2015) 2
... July 21, 2010 In an interview with,financial broadcaster http://www.cantos.com , GlaxoSmithKline ... strong,underlying performance of Emerging Markets, Consumer and Vaccines. , ... The Pharma boss also points to "an unprecedented" five new drugs in late,stage ... , , ...
... 21 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... release tablets. This product was recently approved by the ... Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended ... are therapeutically equivalent to GlaxoSmithKline,s Wellbutrin SR® Extended Release ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... and Regulatory Affairs Officer following the departure of Kristen Dietz, former Chief Operations ... of Healtec® released the following statement welcoming Mr. Salot: “ Stanley H. Salot ...
(Date:9/2/2015)... ... September 02, 2015 , ... Splashtop Inc., the worldwide leader ... screen mirroring and extending product line -- Splashtop Wired XDisplay . ... WIFI setting, the new Splashtop Wired XDisplay delivers enhanced performance and reliability for ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... large stream of mixed documents that include EOBs, payments, and payment related documents. ... the data needed to reconcile their billing, with one efficient process and interface,“ ...
(Date:9/2/2015)... Schwerzenbach, Switzerland (PRWEB) , ... September 02, 2015 ... ... quality control of incoming goods, intermediate or final products. Automating sample handling makes ... and automated sample handling, showing each step of the automated workflow and the ...
(Date:9/2/2015)... ... , ... The medical waste management market is expected to reach USD 13.3 ... The global medical waste management market is segmented based on type of waste, services, ... register the highest growth rate in the medical waste management market, by service, during ...
Breaking Medicine News(10 mins):Health News:Healtec® Announces Executive Leadership Change 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5
... January 12, 2010 (BRONX, NY) Older women ... lesions that cause dementia later in life, according to ... The findings were published in the December 2009 online ... The research was conducted as part of the ...
... WINSTON-SALEM, N.C. A fast-acting compound that appears to ... found in patients with progressive Alzheimer,s disease has been ... Medicine and the Vanderbilt University Medical Center Program in ... result in humans. The compound benzylquinolone carboxylic ...
... ... Molecular Medicine. Molecular Medicine publishes research concerned with the pathogenesis of disease at the ... prevention. , ... January 12, 2010 -- By the time a person experiences symptoms of an aggressive ...
... , DETROIT , Jan. 12 ... Board of Directors has set the date for the Company,s Annual Meeting ... vote at the meeting.   , The Annual Shareholders, Meeting will be ... EST at the MGM Grand Hotel, 1777 Third Street in ...
... hospice and preferred place of death are often needed, experts ... patients have much to consider, from whether they want to ... want doctors to continue aggressive treatment or focus on making ... those difficult, emotional conversations aren,t happening nearly as often, or ...
... WASHINGTON , Jan. 12 The American Lung ... report, which grades the strength of federal and state ... at the heart of America,s chronic disease crisis. , The ... still has significant room for progress. Most state governments , ...
Cached Medicine News:Health News:Hypertension linked to dementia in older women 2Health News:Hypertension linked to dementia in older women 3Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 3Health News:News from the Latest Issue of Molecular Medicine 2Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 2Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 3Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 2Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 2Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 4Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 5Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 6Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 7Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 8